Treatment Strategies for Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis (EBV-HLH)

References

• Imashuku S. Differential diagnosis of hemophagocytic syndrome: underlying disorders and selection of the most effective treatment. Int J Hematol 1997; 66: 135–151
   PubMed Web of Science ®Google Scholar
• Tsuda H. Hemophagocytic syndrome (HPS) in children and adults. Int J Hematol 1997; 65: 215–226
   PubMed Web of Science ®Google Scholar
• Jones J.F., Shurin S., Abramowsky C., Tubbs R.R., Sciotto C.G., Wahl R., Sands J., Gottman D., Katz B.Z., Sklar J. T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr infections. N Engl J Med 1988; 318: 733–741
   PubMed Web of Science ®Google Scholar
• Chen C.L., Sadler R.H., Walling D.M., Su I.J., Hsieh H.C., Raab-Traub N. Epstein-Barr virus (EBV) gene expression in EBV-positive peripheral T-cell lymphomas. J Virol 1993; 67: 6303–6308
   PubMed Web of Science ®Google Scholar
• Anagnostopoulos I., Hummel M., Kreschel C., Stein H. Morphology, immunophenotype and distribution of latently and/or productively Epstein-Barr virus-infected cells in acute infectious mononucleosis: implication for the interindividual infection route of Epstein-Barr virus. Blood 1995; 85: 744–750
   PubMed Web of Science ®Google Scholar
• Kawaguchi H., Miyashita T., Herbst H., Niedobitek G., Asada M., Tsuchida M., Hanada R., Kinoshita A., Sakurai M., Kobayashi N., Mizutani S. Epstein-Barr virus-infected T lymphocytes in Epstein-Barr virus-associated hemophagocytic syndrome. J Clin Invest 1993; 92: 1444–1450
   PubMed Web of Science ®Google Scholar
• Su I.J., Chen R.L., Lin D.T., Lin K.S., Chen C.C. Epstein-Barr virus infects T-lymphocytes in childhood EBV-associated hemophagocytic syndrome in Taiwan. Am J Pathol 1994; 144: 1219–1225
   PubMed Web of Science ®Google Scholar
• Wong K.F., Chan J.K., Lo E.S., Wong C.S. A study of the possible etiologic association of Epstein-Barr virus with reactive hemophagocytic syndrome in Hong Kong Chinese. Hum Pathol 1996; 27: 1239–1242
   PubMed Web of Science ®Google Scholar
• Dreyfus D.H., Kelleher C.A., Jones J.F., Gelfand E.W. Epstein-Barr virus infection of T cells: Implications for altered T-lymphocyte activation, repertoire development and autoimmunity. Immunol Reviews 1996; 152: 89–110
   PubMed Web of Science ®Google Scholar
• Imashuku S., Hibi S., Todo S. Hemophagocytic lymphohistiocytosis in infancy and childhood. J Pediatr 1997; 130: 352–357
   PubMed Web of Science ®Google Scholar
• Henter J-I., Elinder G., Ost A. Diagnostic guidelines for hemophagocytic lymphohistiocytosis. Semin Oncol 1991; 18: 29–33, the HLH Study Group of the Histiocyte Society.
   PubMed Web of Science ®Google Scholar
• Sumaya C.V., Ench Y. Epstein-Barr virus infectious mononucleosis in children. II. Heterophil antibody and viral-specific responses. Pediatrics 1985; 75: 1011–1019
   PubMed Web of Science ®Google Scholar
• Raab-Traub N., Flynn K. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 1986; 47: 883–889
   PubMed Web of Science ®Google Scholar
• Imashuku S., Hibi S., Tabata Y., Sako M, Sekine Y., Hirayama K., Sakazaki H., Maeda N., Kito H., Shichino H., Mugishima H. Biomarker and morphological characteristics of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis. Med Pediatr Oncol 1998; 31: 131–137
   PubMedGoogle Scholar
• Mroczek E.C., Weisenburger D.D., Grierson H.L., Markin R., Purtilo D.T. Fatal infectious mononucleosis and virus-associated hemophagocytic syndrome. Arch Pathol Lab Med 1987; 111: 530–535
   PubMed Web of Science ®Google Scholar
• Wilson E.R., Malluh A., Stagno S., Crist W.M. Fatal Epstein-Barr virus-associated hemophagocytic syndrome. J Pediatr 1981; 98: 260–262
   PubMed Web of Science ®Google Scholar
• Imashuku S., Hibi S., Ohara T., Iwai A., Sako M., Kato M., Arakawa H., Sotomatsu M., Kataoka S., Asami K., Hasegawa D., Kosaka Y., Sano K., Igarashi N., Maruhashi K., Ichimi R., Kawasaki H., Maeda N., Tanizawa A., Arai K., Abe T., Hisakawa H., Miyashita H, Henter J-I. Effective control of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis with immunochemotherapy. Blood 1999; 93: 1869–1874
   PubMed Web of Science ®Google Scholar
• Gaillard R, Mechinaud-Lacroix F, Papin S., Moreau A., Mollat C., Fiche M., Peltier S., De Faucal P.J., Rousselet M.C., Praloran V., Harousseau J.L. Primary Epstein-Barr virus infection with clonal T-cell lymphoproliferation. Am J Clin Pathol 1992; 98: 324–333
   PubMed Web of Science ®Google Scholar
• Cheng A-L., Su I-J., Chen Y-C, Uen W-C, Wang C-H. Characteristic clinicopathologic features of Epstein-Barr virus associated peripheral T cell lymphoma. Cancer 1993; 72: 909–916
   PubMed Web of Science ®Google Scholar
• Yao M., Cheng A-L., Su I-J., Lin M-T, Uen W-C, Tien H-E, Wang C.H., Chen Y.C. Clinicopathological spectrum of haemophagocytic syndrome in Epstein-Barr virus associated T cell lymphoma. Br J Haematol 1994; 87: 535–543
   PubMed Web of Science ®Google Scholar
• Schwartzmann F., von Baehr R., Jager M., Prang N., Bohm S., Reischl U., Wolf H., Bieger W.P. A case of severe chronic active infection with Epstein-Barr virus: Immunologic deficiencies associated with a lytic virus strain. Clin Infect Dis 1999; 29: 626–631
   PubMed Web of Science ®Google Scholar
• Ishihara S., Okada S., Wakiguchi H., Kurashige T, Hirai K., Kawa Ha K. Clonal lymphoproliferation following chronic active Epstein-Barr virus infection and hypersensitivity to mosquito bites. Am J Hematol 1997; 54: 276–281
   PubMed Web of Science ®Google Scholar
• Kanegane H., Wado T, Nunogami K., Seki H., Taniguchi N., Tosato G. Chronic persistent Epstein-Barr virus infection of natural killer cells and B cells associated with granular lymphocytes expansion. Br J Haematol 1996; 95: 116–122
   PubMed Web of Science ®Google Scholar
• Boyd A.W., Ellis D.W., Kannourakis G., Begley C.G., Mackay I.R., Burns G.F. Activated killer cell lymphoma: An erythrophagocytic syndrome simulating histiocytic medullary reticulosis. Pathology 1988; 20: 265–270
   PubMed Web of Science ®Google Scholar
• Okuda T., Sakamoto S., Deguchi T, Misawa S., Kashima K., Yoshihara T., Ikushima S., Hibi S., Imashuku S. Hemophagocytic syndrome associated with aggressive natural killer cell leukemia. Am J Hematol 1991; 38: 321–323
   PubMed Web of Science ®Google Scholar
• Chan J.K., Ng C.S. Malignant lymphoma, natural killer cells and hemophagocytic syndrome. Pathology 1989; 21: 154–155
   PubMed Web of Science ®Google Scholar
• Tokura Y, Ishihara S., Ohshima K., Hidano A., Koide M., Seo N., Takigawa M. Severe mosquito bite hypersensitivity, natural killer cell leukaemia, latent or chronic active Epstein-Barr virus infection and hydroa vacciniforme-like eruption. Br J Dermatol 1998; 138: 905–906
   PubMed Web of Science ®Google Scholar
• Mizuki M., Ueda S., Tagawa S., Shibayama H., Nishimori Y., Shibano M., Asada H., Tanaka M., Nagata S., Koudera U., Suzuki K., Machii T, Ohsawa M., Aozasa K., Kitani T, Kanakura Y. Natural killer cell-derived large granular lymphocyte lymphoma of lung developed in a patient with hypersensitivity to mosquito bites and reactivated Epstein-Barr virus infection. Am J Hematol 1998; 59: 309–315
   PubMed Web of Science ®Google Scholar
• Mizuno S., Akashi K., Ohshima K., Iwasaki H., Miyamoto T, Uchida N., Shibuya T, Harada M., Kikuchi M., Niho Y. Interferon-γ prevents apoptosis in Epstein-Barr virus-infected natural killer cell leukemia in an autocrine fashion. Blood 1999; 93: 3494–3504
   PubMed Web of Science ®Google Scholar
• Larochelle B., Flamand L., Gourde P., Beauchamp D., Gosselin J. Epstein-Barr virus infects and induces apoptosis in human neutrophils. Blood 1998; 92: 291–299
   PubMed Web of Science ®Google Scholar
• Cohen J.I. The biology of Epstein-Barr virus: lessons learned from the virus and the host. Current Opinion in Immunology 1999; 11: 365–370
   PubMed Web of Science ®Google Scholar
• Fischer N., Kopper B., Graf N., Schlehofer J.R., Grasser F.A., Mueller-Lantzsch N. Functional analysis of different LMP1 proteins isolated from Epstein-Barr virus-positive carriers. Virus Res 1999; 60: 41–54
   PubMed Web of Science ®Google Scholar
• Xu J., Menezes J., Prasad U., Ahmad A. Elevated serum levels of transforming growth factor P 1 in Epstein-Barr virus-associated nasopharyngeal carcinoma patients. Int J Cancer 1999; 84: 396–399
   PubMed Web of Science ®Google Scholar
• Feng P., Chan S.H., Ooi E.E., Soo M.Y., Loh K.S., Wang D., Ren E.C., Hu H. Elevated blood levels of soluble tumor necrosis factor receptors in nasopharyngeal carcinoma: correlation with humoral immune response to lytic replication of Epstein-Barr virus. Int J Oncol 1999; 15: 167–172
   PubMed Web of Science ®Google Scholar
• MacKenzie J., Gray D., Pinto-Paes R., Barrezueta L.F.M., Armstrong A.A., Alexander F.A., McGeoch D.J., Jarrett R.F. Analysis of Epstein-Barr virus (EBV) nuclear antigen 1 subtypes in EBV-associated lymphomas from Brazil and the United Kingdom. J Gen Virol 1999; 80: 2741–2745
   PubMed Web of Science ®Google Scholar
• Al-Homsi A.S., Berger C., van Baarle D., Kersten M.J., Klein M.R., McQuain C., van Oers R., Knecht H. Molecular analysis of critical sequences within the EBNA2 type A gene from EBV isolates from patients with infectious mononucleosis, tonsillar hypertrophy, and HIV infection. Int J Mol Med 1998; 1: 983–987
   PubMed Web of Science ®Google Scholar
• Chu P.G., Chang K.L., Chen W.G., Chen Y.Y., Shibata D., Hayashi K., Bacchi C., Bacchi M., Weiss L.M. Epstein-Barr virus (EBV) nuclear antigen (EBNA)-4 mutation in EBV-associated malignancies in three different populations. Am J Pathol 1999; 155: 941–947
   PubMed Web of Science ®Google Scholar
• Hu L.F., Zabarovsky E.R., Chen R, Cao S.L., Ernberg I., Klein G., Winberg G. Isolation and sequence of the Epstein-Barr virus BNLF-1 gene (LMP1) from a Chinese nasopharyngeal carcinoma. J Gen Virol 1991; 72: 2399–2409
   PubMed Web of Science ®Google Scholar
• Liebowitz D. Epstein-Barr virus and a cellular signaling pathway in lymphomas from immunosuppressed patients. New Engl J Med 1998; 338: 1413–1421
   PubMed Web of Science ®Google Scholar
• Knecht H., Bachmann E., Brousset P., Rothenberger S., Einsele H., Lestou VS., Delsol G., Bachmann F., Ambros P.F., Odermatt B.F. Mutational hot spots within the carboxy terminal region of the LMP1 oncogene of Epstein-Barr virus are frequent in lymphoproliferative disorders. Oncogene 1995; 10: 523–528
   PubMed Web of Science ®Google Scholar
• Kingma D.W., Weiss W.B., Jaffe E.S., Kumar S., Frekko K., Raffeld M. Epstein-Barr virus latent membrane protein-1 oncogene deletions: correlations with malignancy in Epstein-Barr virus-associated lymphoproliferative disorders and malignant lymphomas. Blood 1996; 88: 242–251
   PubMed Web of Science ®Google Scholar
• Tabata Y., Hibi S., Teramura T., Kuriyama K., Yagi T., Todo S., Sawada T., Imashuku S. Molecular analysis of latent membrane protein 1 in patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Japan. Leuk Lymphoma 2000, in press
   Web of Science ®Google Scholar
• Kimura H., Morita M., Yabuta Y, Kuzushima K., Kato K., Kojima S., Matsuyama T., Morishima T. Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay. J Clin Microbiol 1999; 37: 132–136
   PubMed Web of Science ®Google Scholar
• Kanegane H., Wakiguchi H., Kanegane C., Kurashige T, Miyawaki T, Tosato G. Increased cell-free viral DNA in fatal cases of chronic active Epstein-Barr virus infection. Clin Infect Dis 1999; 28: 906–909
   PubMed Web of Science ®Google Scholar
• Lo Y.M.D., Chan L.Y.S., Lo K-W., Leung S.-E, Zhang J., Chan A.T.C., Lee J.K.C., Hjelm N.M., Johnson P.J., Huang D.P. Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma. Cancer Res 1999; 59: 1188–1191
   PubMed Web of Science ®Google Scholar
• Lo K.W., Lo Y.M., Leung S.F., Tsang Y.S., Chan L.Y., Johnson P.J., Hjelm N.M., Lee J.C., Huang D.P. Analysis of cell-free Epstein-Barr virus-associated RNA in the plasma of patients with nasopharyngeal carcinoma. Clin Chemistry 1999; 45: 1292–1294
   PubMed Web of Science ®Google Scholar
• Esumi N., Ikushima S., Hibi S., Todo S., Imashuku S. High serum ferritin level as a marker of malignant histiocytosis and virus-associated hemophagocytic syndrome. Cancer 1988; 61: 2071–2076
   PubMed Web of Science ®Google Scholar
• Hibi S., Ikushima S., Fujiwara F., Hashida T., Tsunamoto K., Todo S., Imashuku S. Serum and urine beta-2-microglobulin in hemophagocytic syndrome. Cancer 1995; 75: 1700–1705
   PubMed Web of Science ®Google Scholar
• Imashuku S. Treatment of Epstein-Barr virus (EBV)-associated hemophagocytic syndrome -how to apply immunochemotherapy-. Jpn Med J 1998; 3885, 37-45 (in Japanese)
   Google Scholar
• Imashuku S., Hibi S., Kuriyama K., Tabata Y., Hashida T, Iwai A., Kato M., Yamashita N., Oda M., Uchida M., Kinugawa N., Sawada M., Konno M. Management of severe neutropenia with cyclosporin during initial treatment of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis (EBV-HLH). Leuk Lymphoma 2000, in press
   Web of Science ®Google Scholar
• Imashuku S., Hibi S., Sako M., Ishida Y, Mugishima H., Chen J., Tsunematsu Y. Soluble interleukin-2 receptor: a useful prognostic factor for patients with hemophagocytic lymphohistiocytosis. Blood 1995; 86: 4706–4707
   PubMed Web of Science ®Google Scholar
• Imashuku S., Hibi S., Fujiwara F., Ikushima S., Todo S. Haemophagocytic lymphohistiocytosis, infer-feron-gamma-naemia and Epstein-Barr virus involvement. Br J Haematol 1994; 88: 656–658
   PubMed Web of Science ®Google Scholar
• Imashuku S., Hibi S., Tabata Y, Itoh E., Hashida T., Tsunamoto K., Ishimoto K., Kawano F. Outcome of clonal hemophagocytic lymphohistiocytosis: analysis of 32 cases. Leuk Lymphoma 2000, in press)
   Web of Science ®Google Scholar
• Esumi N., Hashida T, Matsumura T, Takeuchi Y, Arakawa S., Imashuku S. Malignant histiocytosis in childhood. Clinical features and therapeutic results by combination chemotherapy. Am J Pediatr Hematol Oncol 1986; 8: 300–307
   PubMedGoogle Scholar
• Nomura S., Koshikawa K., Hamamoto K., Okubo S., Yasunaga K. Steroid and gamma globulin therapy against virus-associated hemophagocytic syndrome. Rinsho Ketsueki 1992; 33: 1242–1247
   PubMedGoogle Scholar
• Imashuku S. Case records of pediatric hemophagocytic syndrome. Jpn Med J 1994; 3676, 43-52 (in Japanese)
   Google Scholar
• Gill D.S., Spencer A., Cobcroft R.G. High-dose gamma globulin therapy in the reactive hemophagocytic syndrome. Br J Haematol 1994; 88: 204–206
   PubMed Web of Science ®Google Scholar
• Goulder P., Seward D., Hatton C. Intravenous immunoglobulin in virus-associated hemophagocytic syndrome. Arch Dis Child 1990; 65: 1275–1277
   PubMed Web of Science ®Google Scholar
• Freeman B., Rathore M.H., Salman E., Joyce M.J., Pitel P. Intravenously administered immune globulin for the treatment of infection-associated hemophagocytic syndrome. J Pediatr 1993; 123: 479–481
   PubMed Web of Science ®Google Scholar
• Fort D.W., Buchanan G.R. Treatment of infection-associated hemophagocytic syndrome with immune globulin. J Pediatr 1994; 124: 332
   PubMed Web of Science ®Google Scholar
• Chen R.L., Lin K.H., Lin D-T., Su I.J., Huang L.M., Lee P.I., Hseih K.H., Lin K.S., Lee C.Y. Immunomodulation treatment for childhood virus-associated haemophagocytic lymphohistiocytosis. Br J Haematol 1995; 89: 282–290
   PubMed Web of Science ®Google Scholar
• Nagasawa M., Okawa H., Yata J. Deleterious effects of high dose γ-globulin therapy on patients with hemophagocytic syndrome. Int J Hematol 1994; 60: 91–93
   PubMed Web of Science ®Google Scholar
• Osugi Y., Hara J., Tagawa S., Takai K., Hosoi G., Matsuda Y., Ohta H., Fujisaki H., Kobayashi M., Sakata N., Kawa-Ha K., Okada S., Tawa K. Cytokine production regulating Th1 and Th2 cytokines in hemophagocytic lymphohistiocytosis. Blood 1997; 89: 4100–4103
   PubMed Web of Science ®Google Scholar
• Ladisch S., Ho W., Matheson D., Pilkington R., Hartman G. Immunologic and clinical effects of repeated blood exchange in familial erythrophagocytic lymphohistiocytosis. Blood 1982).; 60: 814–821
   PubMed Web of Science ®Google Scholar
• Kizaki Z., Fukumochi H., Sawai T., Ishimura K., Esumi N., Nagai T., Todo S., Imashuku S. Exchange transfusion and combination chemotherapy in the treatment of 4 cases of childhood malignant histiocytosis. Rinsho Ketsueki 1987; 28: 845–851
   PubMedGoogle Scholar
• Matsumoto Y, Naniwa D., Banno S., Sugiura Y. The efficacy of therapeutic plasmapheresis for the treatment of fatal hemophagocytic syndrome: two case reports. Ther Apher 1998; 2: 300–304
   PubMedGoogle Scholar
• Stegmayr B. Apheresis of plasma compounds as a therapeutic principle in severe sepsis and multiorgan dysfunction syndrome. Clin Chem Lab Med 1999; 37: 327–332
   PubMed Web of Science ®Google Scholar
• Clark W.F., Rock G.A., Buskard N., Shumak K.H., LeBlond P., Anderson D., Sutton D.M. Therapeutic plasma exchange: an update from the Canadian Apheresis Group. Ann Intern Med 1999).; 131: 453–462
   PubMed Web of Science ®Google Scholar
• Novitzky N., Jacobs P., Rosenstrauch W. The treatment of thrombotic thrombocytopenic purpura: plasma infusion or exchange?. Br J Haematol 1994; 87: 317–320
   PubMed Web of Science ®Google Scholar
• Oyama Y, Amano T., Hirakawa S., Hironaka K., Suzuki S., Ota Z. Haemophagocytic syndrome treated with cyclosporin A: T cell disorder?. Br J Haematol 1989; 73: 276–278
   PubMed Web of Science ®Google Scholar
• Brinkman K., van Dongen J.J., van Lorn K., Groeneveld K., Misere J.F., van der Heul C. Induction of clinical remission in T-large granular lymphocyte leukemia with cyclosporin A, monitored by use of immunophenotyping with V beta antibodies. Leukemia 1998; 12: 150–154
   PubMed Web of Science ®Google Scholar
• Perel Y, Alos N., Ansoborlo S., Carrere A., Guillard J.M. Dramatic efficacy of antithymocyte globulins in childhood EBV-associated haemophagocytic syndrome. Acta Paediatr 1997; 86: 911
   PubMed Web of Science ®Google Scholar
• Okamoto M., Ono M., Baba M. Potent inhibition of HIV type 1 replication by an anti-inflammatory alkaloid, cepharanthine, in chronically infected monocytic cells. AIDS Res Hum Retroviruses 1998; 14: 1239–1245
   PubMed Web of Science ®Google Scholar
• Sundaram S., Gikakis N., Hack C.E., Niewiarowski S., Edmunds L.H., Koneti-Rao A., Sun L., Cooper S.L., Colman R.W. Nafamostat mesilate, a broad spectrum protease inhibitor, modulates platelet, neutrophil and contact activation in simulated extracorporeal circulation. Thromb Haemostasis 1996; 75: 76–82
   PubMed Web of Science ®Google Scholar
• Senda S., Fujiyama Y, Bamba T., Hosoda S. Treatment of ulcerative colitis with camostat mesilate, a serine protease inhibitor. Intern Med 1993; 32: 350–354
   PubMed Web of Science ®Google Scholar
• Maeda N., Kitoh H., Imashuku S. Epstein-Barr virus-associated hemophagocytic syndrome (EB-VAHS) with neurological symptoms and transient organic mental disorder. Jpn J Pediatr Hematol 1997; 11: 450–454
   Google Scholar
• Iwai A., Iwai T., Suzuya H., Endo S., Nakagawa Y, Watanabe T, Kawano Y, Imashuku S. Development of a clonal and Epstein-Barr virus (EBV)-positive CNS tumor at recurrence in a case of hemophagocytic lymphohistiocytosis. Int J Pediatr Hematol Oncol 1999; 6: 183–188
   Web of Science ®Google Scholar
• Yamashita S., Murakami C., Izumi Y, Sawada H., Yamazaki Y, Yokota T.A., Matsumoto N., Matsukura S. Severe chronic active Epstein-Barr virus infection accompanied by virus-associated hemophagocytic syndrome, cerebellar ataxia and encephalitis. Psychiatry Clin Neurosci 1998; 52: 449–452
   PubMed Web of Science ®Google Scholar
• Morita M., Tsuge I., Matsuoka H., Ito Y, Itosu T, Yamamoto M, Morishima T. Calcification in the basal ganglia with chronic active Epstein-Barr virus infection. Neurology 1998; 50: 1485–1488
   PubMed Web of Science ®Google Scholar
• Ohga S., Takada H., Honda K., Inamura T., Gondo K., Ohshima K., Yamamoto M., Hara T. Central nervous system T-cell lymphoproliferative disorder in a patient with chronic active Epstein-Barr virus infection. J Pediatr Hematol Oncol 1999; 21: 42–46
   PubMed Web of Science ®Google Scholar
• Kinoshita Y, Hashida T, Otsuka T., Hibi S., Sawada T., Imashuku S. A case of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis that died as a result of sepsis of Candida albicans at 1 month after initial treatment. Jpn J Pediatr Hematol 1999; 13: 46–50
   Google Scholar
• Connolly A.A.P., Rowe-Jones J., Leighton S.E.J., Ball S.E., Davies E.G., Moore-Gillon V. Pseudomonal supraglottitis occurring in a patient with profound neutropenia secondary to virus-associated haemophagocytic syndrome. J Laryngol Otol 1992; 106: 739–740
   PubMed Web of Science ®Google Scholar
• Sood R., Stewart C.C., Apian P.D., Murai H., Ward P., Barcos M., Baer M.R. Neutropenia associated with T-cell large granular lymphocyte leukemia: Long-term response to cyclosporine therapy despite persistence of abnormal cells. Blood 1998; 91: 3372–3378
   PubMed Web of Science ®Google Scholar
• Herrod H.G., Wang W.C., Sullivan J.L. Chronic T-cell lymphocytosis with neutropenia. Its association with Epstein-Barr virus infection. Am J Dis Child 1985; 139: 405–407
   PubMedGoogle Scholar
• Garipidou V., Tsatalas C., Sinacos Z. Severe neutropenia in a patient with large granular lymphocytosis: prolonged successful control with cyclosporin A. Haematologica 1991; 76: 424–425
   PubMed Web of Science ®Google Scholar
• Wulff H.R. Acute agranulocytosis following infectious mononucleosis. Report of a case. Scand J Haematol 1976; 2: 179–182
   Google Scholar
• Neel E.U. Infectious mononucleosis. Death due to an agranulocytosis and pneumonia. JAMA 1976; 236: 1493–1494
   PubMed Web of Science ®Google Scholar
• Imashuku S., Hibi S., Morinaga S., Takagi K., Chen J., Mugishima H., Ishii T., Sako M., Arakawa H., Kato M. Haemophagocytic lymphohistiocytosis in association with granular lymphocyte proliferative disorders in early childhood: characteristic bone marrow morphology. Br J Haematol 1997; 96: 708–714
   PubMed Web of Science ®Google Scholar
• Tsuda H., Shirono K. Successful treatment of virus-associated haemophagocytic syndrome in adults by cyclosporin A supported by granulocyte colony-stimulating factor. Br J Haematol 1996; 93: 572–575
   PubMed Web of Science ®Google Scholar
• Quesnel B., Catteau B., Aznar V., Bauters F., Fenaux P. Successful treatment of juvenile rheumatoid arthritis associated haemophagocytic syndrome by cyclosporin A with transient exacerbation by conventional-dose G-CSF. Br J Haematol 1997; 97: 504–510
   Google Scholar
• Kaneko Y., Maseki N., Sakurai M., Ido M., Tsunematsu Y, Mizutani S., Hattori T., Shimizu H., Eguchi H., Oka T., Miyake M., Horikoshi Y, Suchi T. Clonal and non-clonal karyotypically abnormal cells in haemophagocytic lymphohistiocytosis. Br J Haematol 1995; 90: 48–55
   PubMed Web of Science ®Google Scholar
• Dolezal M.V., Kamel O.W., van de Rijn M., Cleary MX., Sibley R.K., Warnke R.A. Virus-associated hemophagocytic syndrome characterized by clonal Epstein-Barr virus genome. Am J Clin Pathol 1995; 103: 189–194
   PubMed Web of Science ®Google Scholar
• Chen J.S., Tzeng C.C., Tsao C.J., Su W.C., Chen T.Y., Jung Y.C., Su I.J. Clonal karyotype abnormalities in EBV-associated hemophagocytic syndrome. Haematologica 1997; 82: 572–576
   PubMed Web of Science ®Google Scholar
• Bird G., Peel D., McCarthy K., Williams H. Epstein-Barr virus induced virus-associated hemophagocytic syndrome and monoclonal TCR-beta rearrangement: A case report. Hematol Oncol 1997; 15: 47–52
   PubMed Web of Science ®Google Scholar
• Henter J.I., Arico M., Egeler R.M., Elinder G., Favara B.E., Filipovich A.H., Gadner H., Imashuku S., Janka-Schaub G., Komp D., Ladisch S., Webb D. HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. Med Pediatr Oncol 1997; 28: 342–347
   PubMedGoogle Scholar
• Imashuku S., Naya M., Yamori M., Nakabayashi Y, Hojo M., Kihara A., Tabata Y, Akioka S., Hibi S., Todo S. Chemotherapy and allogeneic bone marrow transplantation for T-cell/NK-cell type EBV-related lymphoprolif-erative disorders. Jpn J Pediatr Oncol 1996; 33, 369 (abstr, in Japanese)
   Google Scholar
• Inoue M., Nomura K., Yasui M., Okamura T., Sakata N., Yagi K., Kawa K. (1978) 1998 Treatment strategy for hemophagocytic syndrome in childhood-application of stem cell transplantation. Meeting Program of Fourteenth Annual Meeting of the Histiocyte Society, p40. 1998
   Google Scholar
• Canellos G.P., Anderson J.R., Propert K.J., Nissen N., Cooper M.R., Henderson E.S., Green M.R., Gottlieb A., Peterson B.A. Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD. N Engl J Med 1992; 327: 1478–1484
   PubMed Web of Science ®Google Scholar
• Obama K., Tara M., Niina K. L-asparaginase induced complete remission in Epstein-Barr virus positive, multidrug resistant, cutaneous T-cell lymphoma. Int J Hematol 1999; 69: 260–262
   PubMed Web of Science ®Google Scholar
• Fischer A., Cerf-Bensussan N., Blanche S., Le Deist F, Bremard-Oury C., Leverger G., Schaison G., Durandy A., Griscelli C. Allogeneic bone marrow transplantation for erythrophagocytic lymphohistiocytosis. J Pediatr 1986; 108: 267–270
   PubMed Web of Science ®Google Scholar
• Bolme P., Henter J.I., Winiarski J, Elinder G., Ljungman P., Lonnerholm G., Ringden O. Allogeneic bone marrow transplantation for hemophagocytic lymphohistiocytosis in Sweden. Bone Marrow Transplant 1995; IS: 331–335
   Google Scholar
• Collins P., Watts M., Brocklesby M., Gerritsen B., Veys P. Successful engraftment of haploidentical stem cell transplant for familial haemophagocytic lymphohistiocytosis using both bone marrow and peripheral blood stem cells. Br J Haematol 1997; 96: 644–646
   PubMed Web of Science ®Google Scholar
• Jabado N., de Graeff-Meeder E.R., Cavazzana-Calvo M., Haddad E., Le Deist F., Benkerrou M., Dufourcq R., Caillat S., Blanche S., Fischer A. Treatment of Familial Hemophagocytic Lymphohistiocytosis with bone marrow transplantation from HLA genetically nonidentical donors. Blood 1997; 90: 4743–4748
   PubMed Web of Science ®Google Scholar
• Gratama J.W., Oosterveer M.A., Zwaan F.E., Lepoutre J., Klein G., Ernberg I. Eradication of Epstein-Barr virus by allogeneic bone marrow transplantation: Implications for sites of viral latency. Proc Natl Acad Sci USA 1988; 85: 8693–8696
   PubMed Web of Science ®Google Scholar
• Teshima T., Miyaji R., Fukuda M., Ohshima K. Bone-marrow transplantation for Epstein-Barr-virus-associated natural killer cell-large granular lymphocyte leukaemia. Lancet 1996; 347: 1124
   PubMed Web of Science ®Google Scholar
• Imashuku S., Naya M., Yamori M., Nakabayashi Y, Hojo M., Kihara A., Tabata Y, Akioka C., Hibi S., Todo S. Bone marrow transplantation for Epstein-Barr virus-related clonal T cell proliferation associated with hemophagocytosis. Bone Marrow Transplant 1997; 19: 1059–1060
   PubMed Web of Science ®Google Scholar
• Imashuku S., Hibi S., Todo S., Sako M., Inoue M., Kawa K., Koike K., Iwai A., Tsuchiya S., Akiyama Y, Kotani T., Kawamura Y, Hirosawa M., Hasegawa D., Kosaka Y, Yamaguchi H., Ishii E., Kato K., Ishii M., Kigasawa H. Allogeneic hematopoietic stem cell transplantation for patients with hemophagocytic syndrome (HPS) in Japan. Bone Marrow Transplant 1999; 23: 569–572
   PubMed Web of Science ®Google Scholar
• Chan K.W., Mullen C.A., Korbling M. Allogeneic peripheral blood stem cell transplantation for active hemophagocytic lymphohistiocytosis. Bone Marrow transplant 1998; 22: 301–302
   PubMed Web of Science ®Google Scholar
• Ohga S., Nomura A., Kai T., Matsuzaki A., Inaba S., Suda M., Ueda K. Prolonged resolution of hemophagocytic lymphohistiocytosis following myeloablasive chemotherapy and subsequent autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 1997; 19: 633–635
   PubMed Web of Science ®Google Scholar
• Hasegawa D., Sano K., Kosaka Y, Hayakawa A., Nakamura H. A case of hemophagocytic lymphohistiocytosis with prolonged remission after syngeneic bone marrow transplantation. Bone Marrow Transplant 1999; 2A: 425–427
   Web of Science ®Google Scholar
• Anderlini P., Riggs S.A., Korbling M., Champlin R. Syngeneic blood stem cell transplantation for infectious mononucleosis-related aplastic anaemia. Br J Haematol 1999; 106: 159–161
   PubMed Web of Science ®Google Scholar
• Williams L.L., Rooney CM., Conley M.E., Brenner M.K., Krance R.A., Heslop H.E. Correction of Duncan's syndrome by allogeneic bone marrow transplantation. Lancet 1993; 342: 587–588
   PubMed Web of Science ®Google Scholar
• Pracher E., Grumayer-Panzer E.R., Zoubek A., Peters C., Gadner H. Bone marrow transplantation during fulminant EBV-infection in Duncan's syndrome. Lancet 1993; 342: 1362
   PubMed Web of Science ®Google Scholar
• Vowels M.R., Tang R.L., Berdoukas V., Ford D., Thierry D., Purtilo D., Gluckman E. Brief report: Correction of X-linked lymphoproliferative disease by transplantation of cord-blood stem cells. N Engl J Med 1993; 329: 1623–1625
   PubMed Web of Science ®Google Scholar
• Natkunam Y, Smoller B.R., Zehnder J.L., Dorfman R.F., Warnke R.A. Aggressive cutaneous NK and NK-like T-cell lymphomas: clinicopathologic, immunohistochemical, and molecular analyses of 12 cases. Am. J. Surg. Pathol 1999; 23: 571–581
   PubMed Web of Science ®Google Scholar
• Drenou B., Amiot L., Lamy T., Le Prise P.Y., Fauchet R. Multidrug resistance in aggressive lymphoproliferative disorders of T and natural-killer origin. Leuk Lymphoma 1998; 30: 381–387
   PubMed Web of Science ®Google Scholar
• Ohnuma K., Toyoda Y., Nishihira H., Iguchi A., Honda K., Nagao T., Kigasawa H., Tanaka Y, Kikuta H. Aggressive natural killer(NK) cell lymphoma: Report of a pediatric case and review of the literature. Leuk Lymphoma 1997; 25: 387–392
   PubMed Web of Science ®Google Scholar
• Mukai H.Y, Kojima H., Suzukawa K., Hori M., Komeno T., Hasegawa Y, Ninomiya H., Mori N., Nagasawa T. High-dose chemotherapy with peripheral blood stem cell rescue in blastoid natural killer cell lymphoma. Leuk Lymphoma 1999; 32: 583–588
   PubMed Web of Science ®Google Scholar
• Liang R., Chen E, Lee C.K., Kwong Y.L., Chim C.S., Yau C.C., Chiu E. Autologous bone marrow transplantation for primary nasal T/NK cell lymphoma. Bone Marrow Transplant 1997; 19: 91–93
   PubMed Web of Science ®Google Scholar
• Imashuku S., Obayashi M., Hosoi G., Sako M., Chen J., Mugishima H., Tsunamoto K., Hibi S., Todo S. Splenectomy in hemophagocytic lymphohistiocytosis: report of histopathologic changes with CD19+ B-cell depletion and therapeutic results. Br J Haematol 2000, In press
   PubMedGoogle Scholar
• Demeter J. Persistent lymphocytosis of natural killer cells after splenectomy. Br J Haematol 1995; 91: 253–254
   PubMed Web of Science ®Google Scholar
• Loughran T.P., Starkebaum G., Clark E., Wallace P., Kadin M.E. Evaluation of splenectomy in large granular lymphocyte leukaemia. Br J Haematol 1987; 67: 135–140
   PubMed Web of Science ®Google Scholar
• Syruckova Z., Stary J., Sedlacek P., Smisek P., Vavrinec J., Komrska V., Roubalova K., Vandasova J., Sintakova B., Houskova J., Hassan M. Infection-associated hemophagocytic syndrome complicated by infectious lymphoproliferation: a case report. Pediatr Hematol Oncol 1996; 13: 143–150
   PubMed Web of Science ®Google Scholar
• Papadopoulos E.B., Ladanyi M., Emanuel D., Mackinnon S., Boulad R, Carabasi M.H., Castro-Malaspina H., Childs B.H., Gillio A.P., Small T.N., Young J.W., Kernan N.A., O'Reilly R.J. Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N Engl J Med 1994; 330: 1185–1191
   PubMed Web of Science ®Google Scholar
• Moss D.J., Khanna R., Sherritt M., Elliott S.L., Burrows S.R. Developing immunotherapeutic strategies for the control of Epstein-Barr virus-associated malignancies. J AIDS 1999; 21: S80–S83
   PubMed Web of Science ®Google Scholar
• Chiang A.K., Tao Q., Srivastava G., Ho RC. Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease. Int J Cancer 1996; 68: 285–290
   PubMed Web of Science ®Google Scholar
• Roskrow M.A., Suzuki N., Gan Y.J., Sixbey J.W., Ng C.Y., Kimbrough S., Hudson M., Brenner M.K., Heslop H.E., Rooney C.M. Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for the treatment of patients with EBV-positive relapsed Hodgkin's disease. Blood 1998; 91: 2925–2934
   PubMed Web of Science ®Google Scholar
• Seemayer T.A., Grierson H., Pirruccello S.J., Gross T.G., Weisenburger D.D., Davis J., Spiegel K., Brichacek B., Sumegi J. X-linked lymphoproliferative disease. AJDC 1993; 147: 1242–1245
   PubMedGoogle Scholar
• Sayos J., Wu C., Morra M., Wang N., Zhang X., Allen D., van Schaik S., Notarangelo L., Geha R., Roncarolo M.G., Oettgen H., De Vries J.E., Aversa G., Terhorst C. The X-linked lymphoproliferative disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature 1998; 395: 462–469
   PubMed Web of Science ®Google Scholar
• Coffey A.J., Brooksbank R.A., Brandau O., Oohashi X, Howell G.R., Bye J.M., Cahn A.P., Durham J., Heath P., Wray P., Pavitt R., Wilkinson J., Leversha M., Huckle E., Shaw-Smith C.J., Dunham A., Rhodes S., Schuster V., Porta G., Yin L., Serafini P., Sylla B., Zollo M., Franco B., Bolino A, Seri M, Lanyi A, Davis JR, Webster D, Harris A, Lenoir G, de St Basile G, Jones A, Behloradsky BH, Achatz H, Murken J, Fassler R, Sumegi J, Romeo G, Vaudin M, Ross MT, Meindl A, Bentley D.R. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nature Genetics 1998; 20: 129–135
   PubMed Web of Science ®Google Scholar
• Nichols K.E., Harkin D.P., Levitz S., Krainer M., Kolquist K.A., Genovese C., Bernard A., Ferguson M., Zuo L., Snyder E., Buckler A.J., Wise C., Ashley J., Lovett M., Valentine M.B., Look A.T., Gerald W., Housman D.E., Haber D.A. Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome. Proc Natl Acad Sci USA 1998; 95: 13765–13770
   PubMed Web of Science ®Google Scholar
• Nichols K., Arico M., Danesino C., Imashuku S., Haber D. (1978) 1999 Evaluation of DSHP, the gene mutated in X-linked lymphoproliferative disease (XLP), in sporadic EBV-associated hemophagocytic (HLH) or lymphoproliferative (LPD) syndromes. Meeting Program of Fifteenth Annual Meeting of the Histiocyte Society, p40. 1999
   Google Scholar
• Ohadi M., Lalloz M.R., Sham P., Zhao J., Dearlove A.M., Shiach C., Kinsey S., Rhodes M., Layton D.M. Localization of a gene for familial hemophagocytic lymphohistiocytosis at chromosome 9q21.3-22 by homozygosity mapping. Am J Hum Genet 1999; 64: 165–171
   PubMed Web of Science ®Google Scholar
• Dufourcq-Lagelouse R., Jabado N., Le Deist F, Stephan J.L., Souillet G., Bruin M., Vilmer E., Schneider M., Janka G., Fischer A., de Saint Basile G. Linkage of familial hemophagocytic lymphohistiocytosis to 10q21-22 and evidence for heterogeneity. Am J Hum Genet 1999; 64: 172–179
   PubMed Web of Science ®Google Scholar
• Stine K.C., Saylors R.L., Sawyer J.R., Becton D.L. Secondary acute myelogenous leukemia following safe exposure to etoposide. J Clin Oncol 1997; 15: 1583–1586
   PubMed Web of Science ®Google Scholar
• Takahashi T., Yagasaki R, Endo K., Murohashi I, Jinnai I, Bessho M, Hirashima K. Treatment of two cases of severe hemophagocytic syndrome. J Jpn Soc Reticuloen-dothel System 1997; 37, 105 (abstr, in Japanese)
   Google Scholar